Arcutis Biotherapeutics, Inc. planned insider sales
In the last twelve months insiders at Arcutis Biotherapeutics, Inc. filed 59 Form 144 notices of planned sales, 1.0 million shares worth $26.1 million at the time of filing, from 16 sellers. The latest, filed 20 October 2026: Larry Todd Edwards (former officer), 60,376 shares worth $2.0 million, planned for around 20 October 2026 through Merrill Lynch.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 20 October 2026 | Larry Todd Edwards | Former Officer | 60,376 | $2.0 million | 20 October 2026 | None on Form 4 yet | Merrill Lynch | Employee Stock Purchase; Restricted Stock Vesting | Form 144 |
| 15 October 2026 | Howard Welgus | Director | 4,728 | $127,325 | 15 October 2026 | 4,728 shares from 15 October 2026 | Merrill Lynch | Restricted Stock Vesting; Stock Option Exercise | Form 144 |
| 16 September 2026 | Larry Todd Edwards | Former Officer | 341,980 | $8.5 million | 16 September 2026 | None on Form 4 yet | Merrill Lynch | Stock Option Exercise | Form 144 |
| 15 September 2026 | Howard Welgus | Director | 4,730 | $114,371 | 15 September 2026 | 4,730 shares from 15 September 2026 | Merrill Lynch | Restricted Stock Vesting; Stock Option Exercise | Form 144 |
| 8 September 2026 | Masaru Matsuda | Officer | 13,663 | $341,933 | 8 September 2026 | 13,663 shares from 8 September 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 27 August 2026 | Terrie Curran | Director | 38,200 | $956,125 | 27 August 2026 | 38,200 shares from 27 August 2026 | Merrill Lynch | Stock Option Exercise | Form 144 |
| 20 August 2026 | Terrie Curran | Director | 1,072 | $27,912 | 20 August 2026 | 1,072 shares from 20 August 2026 | Merrill Lynch | Stock Option Exercise | Form 144 |
| 19 August 2026 | Patrick Burnett | Officer | 1,697 | $45,819 | 19 August 2026 | 1,697 shares from 19 August 2026 | Merrill Lynch | Restricted Stock Vest | Form 144 |
| 17 August 2026 | Howard Welgus | Director | 4,730 | $123,835 | 17 August 2026 | 4,730 shares from 17 August 2026 | Merrill Lynch | Restricted Stock Vesting; Stock Option Exercise | Form 144 |
| 11 August 2026 | Patrick Burnett | Officer | 15,000 | $397,824 | 11 August 2026 | 15,000 shares from 11 August 2026 | Merrill Lynch | Stock Option Exercise | Form 144 |
| 3 August 2026 | Patrick Burnett | Officer | 955 | $24,942 | 3 August 2026 | 955 shares from 3 August 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 3 August 2026 | Matsuda Masaru | Officer | 1,230 | $32,124 | 3 August 2026 | 1,230 shares from 3 August 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 3 August 2026 | Todd Frank Watanabe | Officer | 4,375 | $114,261 | 3 August 2026 | 4,375 shares from 3 August 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 15 July 2026 | Howard Welgus | Director | 4,730 | $127,284 | 15 July 2026 | 4,730 shares from 15 July 2026 | Merrill Lynch | Restricted Stock Vesting; Stock Option Exercise | Form 144 |
| 17 June 2026 | Howard Welgus | Director | 635 | $16,300 | 17 June 2026 | 635 shares from 17 June 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 15 June 2026 | Howard Welgus | Director | 4,096 | $99,980 | 15 June 2026 | 4,096 shares from 15 June 2026 | Merrill Lynch | Stock Option Exercise | Form 144 |
| 15 June 2026 | Sue-Jean Lin | Officer | 4,946 | $120,587 | 15 June 2026 | 4,946 shares from 15 June 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 11 May 2026 | Patrick Burnett | Officer | 222 | $4,673 | 11 May 2026 | 222 shares from 11 May 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 11 May 2026 | Latha Vairavan | officer | 435 | $9,157 | 11 May 2026 | 435 shares from 11 May 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 4 May 2026 | Patrick Burnett | Officer | 684 | $16,150 | 4 May 2026 | 684 shares from 4 May 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 4 May 2026 | Latha Vairavan | Officer | 1,341 | $31,662 | 4 May 2026 | 1,341 shares from 4 May 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 4 May 2026 | Todd Watanabe | Officer | 3,172 | $74,893 | 4 May 2026 | 3,172 shares from 4 May 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 4 May 2026 | Masaru Matsuda | officer | 8,256 | $192,416 | 4 May 2026 | 8,256 shares from 4 May 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 1 May 2026 | Howard Welgus | Director | 7,144 | $164,220 | 1 May 2026 | 7,144 shares from 1 May 2026 | Merrill | Stock option exercise | Form 144 |
| 1 April 2026 | Howard Welgus | Director | 10,000 | $238,801 | 1 April 2026 | 10,000 shares from 1 April 2026 | Merrill | Stock option exercise | Form 144 |
| 2 March 2026 | Latha Vairavan | officer | 2,853 | $71,845 | 2 March 2026 | 2,853 shares from 2 March 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 March 2026 | Larry Todd Edwards | Officer | 3,687 | $92,846 | 2 March 2026 | 3,687 shares from 2 March 2026 | Merrill Lynch | Restricted Stock Vest | Form 144 |
| 2 March 2026 | Patrick Burnett | Officer | 6,287 | $158,320 | 2 March 2026 | 6,287 shares from 2 March 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 March 2026 | Howard Welgus | Director | 10,000 | $256,518 | 2 March 2026 | 10,000 shares from 2 March 2026 | Merrill | Stock option exercise | Form 144 |
| 2 March 2026 | Masaru Matsuda | officer | 12,058 | $313,878 | 2 March 2026 | 8,733 shares from 2 March 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 March 2026 | Todd Watanabe | Officer | 37,349 | $940,526 | 2 March 2026 | 37,349 shares from 2 March 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 March 2026 | Keith Leonard | Board of Director | 39,272 | $997,195 | 2 March 2026 | 39,272 shares from 2 March 2026 | Merrill | Stock option exercise | Form 144 |
| 4 February 2026 | Patrick Burnett | Officer | 9,794 | $252,748 | 4 February 2026 | 9,794 shares from 4 February 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 February 2026 | Latha Vairavan | Officer | 1,320 | $33,658 | 2 February 2026 | 1,320 shares from 2 February 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 February 2026 | Todd Edwards | Officer | 2,052 | $52,323 | 2 February 2026 | 2,052 shares from 2 February 2026 | Merrill | Restricted shares vest | Form 144 |
| 2 February 2026 | Patrick Burnett | Officer | 3,675 | $93,707 | 2 February 2026 | 3,675 shares from 2 February 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 February 2026 | Howard Welgus | Director | 10,000 | $250,483 | 2 February 2026 | 10,000 shares from 2 February 2026 | Merrill | Stock option exercise | Form 144 |
| 2 February 2026 | Todd Frank Watanabe | officer | 19,833 | $505,710 | 2 February 2026 | 19,833 shares from 2 February 2026 | Merrill | Restricted stock vest | Form 144 |
| 2 February 2026 | Masaru Matsuda | officer | 40,638 | $1.0 million | 2 February 2026 | 43,963 shares from 2 February 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 5 January 2026 | Patrick Burnett | Officer | 2,490 | $72,166 | 5 January 2026 | 2,490 shares from 5 January 2026 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 2 January 2026 | Howard Welgus | Director | 10,000 | $289,606 | 2 January 2026 | 10,000 shares from 2 January 2026 | Merrill | Stock option exercise | Form 144 |
| 31 December 2025 | Patrick Burnett | Officer | 1,697 | $49,561 | 31 December 2025 | 1,697 shares from 31 December 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 15 December 2025 | Patrick Burnett | Officer | 11,500 | $332,851 | 15 December 2025 | 11,500 shares from 15 December 2025 | Merrill Lynch | Stock Option Exercise | Form 144 |
| 1 December 2025 | Masaru Matsuda | Officer | 1,657 | $50,091 | 1 December 2025 | 1,657 shares from 1 December 2025 | Merrill Lynch | Employee Stock Purchase Plan | Form 144 |
| 1 December 2025 | Howard Welgus | Director | 10,000 | $302,133 | 1 December 2025 | 10,000 shares from 1 December 2025 | Merrill | Stock option exercise | Form 144 |
| 24 November 2025 | Sue-Jean Lin | Director | 25,272 | $777,956 | 24 November 2025 | 25,272 shares from 24 November 2025 | Merrill | Stock option exercise | Form 144 |
| 24 November 2025 | Todd Franklin Watanabe | Officer | 48,945 | $1.5 million | 24 November 2025 | 48,945 shares from 24 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 21 November 2025 | Todd Franklin Watanabe | Officer | 1,055 | $31,650 | 21 November 2025 | 1,055 shares from 21 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 20 November 2025 | Halley Gilbert | Director | 16,532 | $455,442 | 20 November 2025 | 16,532 shares from 20 November 2025 | Merrill | Restricted stock vest; Stock option exercise | Form 144 |
| 19 November 2025 | Masaru Matsuda | Officer | 2,550 | $72,133 | 19 November 2025 | 2,550 shares from 19 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 13 November 2025 | Neha Krishnamohan | Director | 40,504 | $939,273 | 13 November 2025 | 40,504 shares from 13 November 2025 | Merrill | Restricted stock vest; Stock option exercise | Form 144 |
| 6 November 2025 | Patrick Burnett | Officer | 17,250 | $417,145 | 6 November 2025 | 21,114 shares from 5 November 2025 | Merrill Lynch | Stock Option Exercise | Form 144 |
| 5 November 2025 | Patrick Burnett | Officer | 3,846 | $91,216 | 5 November 2025 | No matching Form 4 sale | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 3 November 2025 | Latha Vairavan | Officer | 88 | $2,175 | 3 November 2025 | 88 shares from 3 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 3 November 2025 | Patrick Burnett | Officer | 2,622 | $64,806 | 3 November 2025 | 2,622 shares from 3 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 3 November 2025 | Masaru Matsuda | Officer | 7,208 | $178,155 | 3 November 2025 | 7,208 shares from 3 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 3 November 2025 | Howard Welgus | Director | 10,000 | $252,669 | 3 November 2025 | 10,000 shares from 3 November 2025 | Merrill | Stock option exercise | Form 144 |
| 3 November 2025 | Todd Franklin Watanabe | Officer | 11,547 | $285,399 | 3 November 2025 | 11,547 shares from 3 November 2025 | Merrill Lynch | Restricted Stock Vesting | Form 144 |
| 28 October 2025 | Todd F watanabe | officer | 40,000 | $1.0 million | 28 October 2025 | 40,000 shares from 28 October 2025 | Merrill | Restricted stock vest | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.